|
| | 
|
 | |
          
|  |
|  |
(Login BolsaPT & Canal Forex) |
|
 Sepracor Inc. - [Ticker: SEPR] |     | | Última Trade | 0,000 | Range 52 Semanas | [0,000 - 0,000] | | Hora da Última Trade | - 00:00:00 | Price-Target 1 Ano | 0,000 | | Variação | N/A (N/A) | Capitalização Bolsista | 0 | | Bid / Ask | N/A | EPS | 0,00 | | Abertura | 0,000 | PER | 0,00% | | Máximo | 0,000 | Pagamento Dividendo | | | Mínimo | 0,000 | Data Ex-Dividendo | | | Fecho Anterior | 0,000 | Yield | | | Volume | 0 | Volume Médio (3m) | 0 | | Nota: Os dados podem apresentar atraso de alguns minutos. |
| | Ver cotações de outros activos |
| Últimos 10 Tópicos no Fórum sobre Sepracor Inc.: | | Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc.. |
|
Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)
|
County Telegram |
Global Asthma Medication Market Research Study including Growth Factors, Competitive Analysis by regions And Top ...County TelegramDulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The regional examination has been done to precisely ... |
Latest Market Reports By Abhishek Budholiya (press release) (blog) |
Expansion of Allergy Treatment Market During 2016-2026 to Gain Robust TractionLatest Market Reports By Abhishek Budholiya (press release) (blog)... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. |
|
Allergan Medicaid Rebate Suit Redo Denied At 3rd Circ.Law360Law360 (September 26, 2018, 7:11 PM EDT) -- The Third Circuit on Wednesday again refused to revive a pharmaceutical executive's suit claiming Allergan Inc. and other drug manufacturers shorted the federal government on drug rebate payments. |
LANews By Abhishek Budholiya (press release) (blog) |
Allergy Treatment Market to Register Steady Expansion During 2016-2026LANews By Abhishek Budholiya (press release) (blog)... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.e mais » |
OutSourcing-Pharma.com |
GA-based CDMO picked up by private equityOutSourcing-Pharma.comMikart, Inc. provides a range of services, including formulation development, clinical trial supplies, regulatory filing support, as well as clinical and commercial manufacturing, among others. According to the company, ongoing investments in the ... |
WhaTech |
Global Asthma Medication Market Research Report for 2018 scrutinized in new researchWhaTechTop Key Players. Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The territorial examination has been ... |
| Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. |
|
Largura do Site:
Imagem de Fundo: |
|  | |
|
|
![Gráfico de Sepracor Inc. - [Ticker: SEPR]](http://www.bolsapt.com/grafico/bolsapt-SEPR-6-meses.png "Gráfico 6 Meses de Sepracor Inc. [SEPR] BolsaPT")
